Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2021-02-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuromuscular Electrical Stimulation (NMES) Preserves Muscle Mass in Intensive Care Unit (ICU)
NCT05287919
Effects of Neuromuscular Electrical Stimulation on Critically Ill Patients With Mechanical Ventilation
NCT05217511
Bed Rest and Muscle Strength in ICU: Interest in the Early Association of NEMS With Cyclo-ergometer Mobilization
NCT03987997
NMES Role to Prevent Respiratory Muscle Weakness in Critically Ill Patients and Its Association to Changes in Myokines.
NCT05536531
The Effect of Neuromuscular Electrical Stimulation
NCT00442728
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
Group that will receive a standard care from physiotherapy staff not involved in delivering the intervention whenever feasible.
No interventions assigned to this group
50 electrically evoked contractions
Group that will receive a standard care from physiotherapy staff plus neuromuscular electrical stimulation with the following parameters: pulsed current; freqeuncy 50Hz; pulse witdh 400 us, current intensity that get level 4/5 of evoked contractions proposed by Segers et al; on/off time and duration of therapy that allow 50 ellectrically evoked contractions with surface electrodes positioned on the quadriceps femoris.
neuromuscular electrical stimulation
application of an electric current through electrodes placed on the skin over the targeted musclesto induce skeletal muscle contractions
100 electrically evoked contractions
Group that will receive a standard care from physiotherapy staff plus neuromuscular electrical stimulation with the following parameters: pulsed current; freqeuncy 50Hz; pulse witdh 400 us, current intensity that get level 4/5 of evoked contractions proposed by Segers et al; on/off time and duration of therapy that allow 100 ellectrically evoked contractions with surface electrodes positioned on the quadriceps femoris.
neuromuscular electrical stimulation
application of an electric current through electrodes placed on the skin over the targeted musclesto induce skeletal muscle contractions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
neuromuscular electrical stimulation
application of an electric current through electrodes placed on the skin over the targeted musclesto induce skeletal muscle contractions
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intubated and expected to remain invasively mechanically ventilated the day after tomorrow
* laboratory confirmed COVID-19 (diagnosis of SARS-CoV-2 via reverse transcriptase polymerase chain reaction as per the World Health Organization protocol or by nucleic acid based isothermal amplification)
Exclusion Criteria
* Documented cognitive impairment.
* Proven or suspected spinal cord injury or other neuromuscular disease that will result in permanent or prolonged weakness (not including ICU acquired weakness)
* Death is deemed inevitable as a result of the current illness and either the patient or treating clinical or substitute decision maker are not committed to full active treatment
* pregnancy
* patients with unstable fractures in the vertebral column and lower limbs.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Escola Superior de Ciencias da Saude
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vinicius Zacarias Maldaner da silva
Principal Inverstigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
VINICIUS ZACARIAS MALDANER D SILVA
Role: PRINCIPAL_INVESTIGATOR
Secretaria de Saúde do Distrito Federal
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Secretaria de Saúde do Distrito Federal
Brasília, Federal District, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FAP042017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.